Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro70

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro14

Views

Views
October 20252
November 20251
December 20254
January 20262
February 20261
March 20263
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
United Kingdom3
France2
Brazil2
Argentina1
Ethiopia1
Mexico1
 

Top cities views

Views
Addis Ababa1
Cascavel1
Guadalajara1
Laferrere1
Philadelphia1
São Paulo1